DGX
Quest Diagnostics Incorporated
246.50$
-0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.6% | +32.0% | +9.9% | +2.1% | +3.6% | +61.3% | +11.4% | -23.1% | -26.0% | +4.9% | +41.4% | |
| – | -3.2% | -18.1% | +8.4% | +14.4% | +6.5% | +9.7% | +13.0% | +7.1% | +0.5% | +12.3% | +15.6% | |
| – | +2.0% | +32.7% | +14.5% | -22.8% | -8.2% | +73.2% | -18.6% | -2.5% | +0.0% | +14.3% | +0.0% | |
| – | -64.2% | +126.6% | +36.9% | -61.7% | -117.8% | – | -308.9% | – | – | – | – | |
| – | – | – | – | – | – | -37.1% | +295.5% | +36.8% | -221.8% | – | – | |
| – | -14.6% | +11.4% | -14.0% | +52.0% | +4.4% | +4.5% | -3.6% | +0.2% | +1.0% | +4.2% | +24.0% | |
| – | -64.7% | -58.0% | +429.6% | -0.5% | -48.7% | +87.8% | – | -2,685.7% | +95.4% | +140.2% | -75.2% | |
| – | +13.4% | +5.2% | +10.8% | +7.7% | +7.5% | +3.8% | +4.0% | -1.3% | +3.0% | +5.4% | +6.6% | |
| – | +69.7% | +163.4% | -21.2% | -30.8% | +9.6% | -7.9% | +576.6% | -36.0% | -80.5% | -45.1% | +198.0% | |
| – | -122.6% | – | -84.1% | +439.1% | +571.0% | -196.8% | -99.8% | +0.0% | – | +106.3% | -139.0% | |
| – | -651.1% | +36.3% | -14.3% | -32.3% | – | -663.1% | +100.5% | -31.8% | – | +577.5% | -228.0% | |
| – | -1,280.0% | – | -198.2% | – | – | -103.2% | – | – | – | -136.9% | – | |
| – | -13.2% | +41.9% | +18.9% | -11.5% | +3.2% | +88.3% | +15.3% | -28.2% | -34.2% | +5.2% | +49.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.